REVIEW ARTICLE

Ketamine: old drug, a new option

Susilo Chandra

Susilo Chandra
Department of Anesthesia and Intensive Care Faculty of Medicine, University of Indonesia, Jakarta -Indonesia. Email: susilochandra@hotmail.com
Online First: April 30, 2019 | Cite this Article
Chandra, S. 2019. Ketamine: old drug, a new option. Bali Journal of Anesthesiology 3(1): 74-77. DOI:10.15562/bjoa.v3i1.151


Unique properties and recent development in the areas of clinical properties of ketamine make this agent to be popular for a long time. This anesthetic agent has wide range of indications. Many areas of clinical application of ketamine are explored in many studies. However, not many clinicians are familiar with the wide range of clinical applications of ketamine. As time passes there are many new alternative use of ketamine, a well-established anesthetic agent. The analgesic profile of ketamine is explored to have more benefits, such as postoperative pain control and as preemptive analgesia. The other aspect, which has been studied extensively, is the neuroprotective profile of ketamine. The  administration of ketamine is not associated with increased intracranial pressure if normocapnia is achieved, making it possible anesthetic for neurosurgery. The other areas to explore include the role of ketamine to prevent opioid-induced acute tolerance and treat major depressive disorder.

References

REFERENCES

Mion G. History of anesthesia: the ketamine story – past, present and future. Eur J Anaesth. 2017; 34(9): 571-5. DOI: 10.1097/EJA.0000000000000638

Li L, Vilsides PE. Ketamine: 50 years of modulating the mind. Front Hum Neurosci. 2016; 10: 612. DOI: 10.3389/fnhum.2016.00612

Mion G, Villevielle T. Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings). CNS Neurosci Ther. 2013; 19(6): 370-80. DOI: 10.1111/cns.12099

Pai A, Heining M. Ketamine. Cont Edu Anaesth Crit Care Pain. 2007; 7(2): 59-63. DOI: 10.1093/bjaceaccp/mkm008

Brinck ECV, Tiippana E, Heesen M, et al. Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database of Systematic Reviews. 20176; 1: 1-11. DOI: 10.1002/14651858.CD012033

Radvansky B, Shah K, Parikh A, et al. Role of ketamine in acute postoperative pain management: a narrative review. Biomed Res Int. 2015; Article ID 749837. DOI: 10.1155/2015/749837

Aroni F, Iacovidou N, Dontas I, et al. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J Clin Pharma. 2009; 49(8): 957–64. DOI: 10.1177/0091270009337941

Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as an adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg. 2004; 99(2): 482–95. DOI: 10.1213/01.ANE.0000118109.12855.07

Yang L, Zhang J, Zhang Z, et al. Preemptive analgesic effects of ketamine in patients undergoing surgery. A meta-analysis. Acta Cir Bras. 2014; 29(12): 819-25. DOI: 10.1590/S0102-86502014001900009

Singh H, Kundra S, Singh RM, et al. Preemptive analgesia with Ketamine for Laparoscopic cholecystectomy. J Anaesthesiol Clin Pharmacol. 2013; 29(4): 478–84. DOI: 10.4103/0970-9185.119141

Bowles ED, Gold ME. Rethinking the paradigm: evaluation of ketamine as a neurosurgical anesthetic. AANA J. 2012; 80(6): 445-52. Available at: https://www.ncbi.nlm.nih.gov/pubmed/23409639

Chang LC, Raty SR, Ortiz J, et al. The Emerging Use of Ketamine for Anesthesia and Sedation in Traumatic Brain Injuries. CNS Neurosci Ther. 2013; 19(6): 390-5. DOI: 10.1111/cns.12077

Zeiler FA, Sader N, Gillman LM, et al. The cerebrovascular response to ketamine: a systematic review of animal and human literature. J Neurosurg Anest. 2016; 28)2): 123-40. DOI: 10.1097/ANA.0000000000000234.

Kissin I, Bright CA, Bradley EL. The effect of ketamine on opioid-induced acute tolerance: can it explain the reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg. 2000; 91(6): 1483-8. DOI: 10.1097/00000539-200012000-00035

Lilius T, Kangas E, Niemi M, et al. Ketamine and norketamine attenuate oxycodone tolerance markedly less than that of morphine: from behavior to drug availability. British J Anaesth. 2018; 120(4): 818-26. DOI: 10.1016/j.bja.2017.11.081

Grady SE, Marsh TA, Tenhouse A, et al. Ketamine for the treatment of the major depressive disorder and bipolar depression: A review of the literature. Ment Health Clin. 2018; 7(1): 16-23. DOI: 10.9740/mhc.2017.01.016

Romeo B, Choucha W, Fossati P, et al. Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression. Psychiatry Res. 2015; 230 2: 682- 8. DOI: 10.1016/j.psychres.2015.10.032.


No Supplementary Material available for this article.
Article Views      : 298
PDF Downloads : 136

Related Articles

Search Authors in












  • Susilo Chandra

  • Susilo Chandra

  • Susilo Chandra